samedan logo
 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

SERVICES TO PHARMACEUTICAL INDUSTRY PROVE WINNING FORMULA FOR A4P

Since its launch five years ago, problem solving has been the USP for A4P, quickly gaining a global reputation for success

More>>

 
phone +44 (0)1304 249106
email info@a4pbio.com
web www.a4pbio.com/
email G.436 Innovation House, Discovery Park, Ramsgate Road, Sandwich, CT13 9ND, Kent
 

Plasticell signs stem cell research collaborations with leading Singapore academic institutions

Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline. More>>

 
phone +44 203 384 0244
web www.plasticell.co.uk/
email Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX
 

Global Industry Research Leader MarketsandMarkets Raises $56 Million in Growth Equity Led by FTV Capital

Custom research provider continues to capture market share in a data-driven world

More>>

 
phone 1-888-600-6441
email sales@marketsandmarkets.com
web www.marketsandmarkets.com
email UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
 

Aptar Pharma Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with RESTASIS Multidose™

More>>

 
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 

Wickham Labs to Exhibit at Med-Tech Innovation Expo 2017

Wickham Laboratories Ltd is pleased to announce that we will be on Stand 12 at the upcoming Med-Tech Innovation Expo, Ricoh Arena, Coventry, April 26-27.

More>>

 
phone +44 (0)1329 226600
email marketing@wickhamlabs.co.uk
web www.wickhamlabs.co.uk/
email Hoeford Point, Barwell Lane, Gosport, Hampshire, PO13 0AU, United Kingdom
 

Nemera has won the ‘Editor’s choice’ category at the annual INTERPHEX Awards, for its 2 steps-autoinjector Safelia®

INTERPHEX and a team of industry experts select Nemera (booth 1636) as winner for this year’s exhibitor awards as Editor’s choice

More>>

 
phone +33 4 74 94 06 54
email information@nemera.net
web www.nemera.net
email 20 avenue de la Gare, 38290 – La Verpilličre, France
 

PCI Clinical Services Announces Additional Cryogenic Storage Capacity at its Rockford, IL Site

Leading pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced a second phase 400 percent increase in Cyrogenic storage capabilities at its Rockford, Illinois site. The announcement follows PCI’s initial capital investment in specialist cryogenic storage in Rockford in November last year – investment that complements existing LN2 storage capability at its Bridgend site, a center of excellence for Clinical Trial services in the UK. More>>

 
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 

Aptar Pharma Inaugurates Congers Site Expansion

Aptar Pharma’s site expansion in Congers, NY will be inaugurated on March 20th by Stephan Tanda, AptarGroup’s President and CEO, Salim Haffar, President of Aptar Pharma, and Alex Theodorakis, President Aptar Pharma North America. Several Aptar Pharma customers in North America have been invited to attend this inaugural event. More>>

 
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 

DrugDev Dominates Clinical Site Payments with Record Milestone of Over $2 Billion Processed to Sites on Behalf of Sponsors and CROs Worldwide

Currently disbursing $40M per month, no other payments provider approaches DrugDev’s global experience and scale with over 26,000 site recipients in 60 countries on 1,800 trials

More>>

 
phone +1 888 650 1860
email solutions@drugdev.com
web www.drugdev.com/
email 1170 Devon Park Drive Suite 300, Wayne, PA 19087
 

Natoli Engineering Company Opens Facility in Poland

Launches New International Division

More>>

 
phone 636.926.8900
email info@natoli.com
web www.natoli.com
email 28 Research Park Circle, Saint Charles, MO 63304, US
 
 
spacer
News and Press Releases

MRC Technology monetises royalties on cancer drug Keytruda (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital


More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

Industry Events

T3: Trials, Tech and Transformation 2017

11-12 May 2017, Orlando, FL

T3: Trials, Tech and Transformation will unite key stakeholders from pharmaceutical, biotech, and medical device companies, clinical research organizations, and clinical sites to accelerate clinical development, improve trial quality and deliver knowledge that puts the patient first.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement